BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38253131)

  • 1. Wogonin alleviates NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/SIRT1.
    Cheng Z; Tu J; Wang K; Li F; He Y; Wu W
    Brain Res Bull; 2024 Feb; 207():110886. PubMed ID: 38253131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway.
    Ma C; Wang X; Xu T; Yu X; Zhang S; Liu S; Gao Y; Fan S; Li C; Zhai C; Cheng F; Wang Q
    BMC Complement Altern Med; 2019 Nov; 19(1):320. PubMed ID: 31747940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation.
    Li X; Yao M; Li L; Ma H; Sun Y; Lu X; Jing W; Nie S
    Phytomedicine; 2024 Jul; 129():155578. PubMed ID: 38621328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction.
    He Q; Li Z; Wang Y; Hou Y; Li L; Zhao J
    Int Immunopharmacol; 2017 Sep; 50():208-215. PubMed ID: 28683365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling.
    Qiu J; Wang M; Zhang J; Cai Q; Lu D; Li Y; Dong Y; Zhao T; Chen H
    Int Immunopharmacol; 2016 Nov; 40():492-500. PubMed ID: 27769021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury.
    Zheng WX; He WQ; Zhang QR; Jia JX; Zhao S; Wu FJ; Cao XL
    Inflammation; 2021 Oct; 44(5):2091-2105. PubMed ID: 34080089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLDA1 Blockade Alleviates Cerebral Ischemia/Reperfusion Injury by Affecting Microglial M1/M2 Polarization and NLRP3 Inflammasome Activation.
    Zhao H; Liu Y; Chen N; Yu H; Liu S; Qian M; Zhang Z
    Neuroscience; 2022 Apr; 487():66-77. PubMed ID: 35093445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bakuchiol ameliorates cerebral ischemia-reperfusion injury by modulating NLRP3 inflammasome and Nrf2 signaling.
    Xu Y; Gao X; Wang L; Yang M; Xie R
    Respir Physiol Neurobiol; 2021 Oct; 292():103707. PubMed ID: 34087492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro.
    Ma DC; Zhang NN; Zhang YN; Chen HS
    J Ethnopharmacol; 2021 Apr; 270():113776. PubMed ID: 33421597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Gingerol protects against cerebral ischemia/reperfusion injury by inhibiting NLRP3 inflammasome and apoptosis via TRPV1 / FAF1 complex dissociation-mediated autophagy.
    Luo J; Chen J; Yang C; Tan J; Zhao J; Jiang N; Zhao Y
    Int Immunopharmacol; 2021 Nov; 100():108146. PubMed ID: 34537481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of NLRP3-IL-1β Signals in Cerebral Ischemia and Reperfusion Injury: from Microglia to Adjacent Neuron and Endothelial Cells via IL-1β/IL-1R1/TRAF6.
    Pan J; Peng J; Li X; Wang H; Rong X; Peng Y
    Mol Neurobiol; 2023 May; 60(5):2749-2766. PubMed ID: 36717480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition.
    Shi M; Wang J; Bi F; Bai Z
    Environ Toxicol; 2022 Jun; 37(6):1529-1542. PubMed ID: 35191607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β.
    Liu H; Wu X; Luo J; Zhao L; Li X; Guo H; Bai H; Cui W; Guo W; Feng D; Qu Y
    Exp Neurol; 2020 Jul; 329():113302. PubMed ID: 32275928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narirutin Attenuates Cerebral Ischemia-Reperfusion Injury by Suppressing the TXNIP/NLRP3 Pathway.
    Luo L; Wang S; Liu W; Zhang Z; Zhao M; Liu A
    Neurochem Res; 2024 Mar; 49(3):692-705. PubMed ID: 38047987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 improves cerebral ischemia-reperfusion injury and cognitive dysfunction by regulating miR-142-3p/SIRT1 axis.
    Meng S; Wang B; Li W
    Int J Neurosci; 2023 Jul; 133(7):740-753. PubMed ID: 34461809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anfibatide alleviates inflammation and apoptosis via inhibiting NF-kappaB/NLRP3 axis in ischemic stroke.
    Li R; Si M; Jia HY; Ma Z; Li XW; Li XY; Dai XR; Gong P; Luo SY
    Eur J Pharmacol; 2022 Jul; 926():175032. PubMed ID: 35584710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA binding protein RPS3 mediates microglial polarization by activating NLRP3 inflammasome via SIRT1 in ischemic stroke.
    Zhou D; Chen L; Wang Y; Gan L; Yuan M; Zhang L; Chen F
    J Stroke Cerebrovasc Dis; 2023 Jun; 32(6):107132. PubMed ID: 37087770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis.
    Shi M; Chen J; Liu T; Dai W; Zhou Z; Chen L; Xie Y
    Drug Des Devel Ther; 2022; 16():413-423. PubMed ID: 35210755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JLX001 ameliorates cerebral ischemia injury by modulating microglial polarization and compromising NLRP3 inflammasome activation via the NF-κB signaling pathway.
    Bian HJ; Xu SY; Li HQ; Jia JQ; Ye L; Shu S; Xia SN; Gu Y; Zhu X; Xu Y; Cao X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108325. PubMed ID: 34740080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.